Antithrombotic therapy following bioprosthetic aortic valve replacement.
about
Antithrombotic strategy in the three first months following bioprosthetic heart valve implantation.The optimal management of anti-thrombotic therapy after valve replacement: certainties and uncertainties.Aortic valve replacement in an elderly patient with factor XI deficiency.Pharmacogenetics-Based Warfarin Dosing in Patients With Cardiac Valve Replacement: The Effects of CYP2C9 and VKORC1 Gene Polymorphisms.[ESC guidelines on the management of valvular heart disease. What has changed and what is new?].
P2860
Antithrombotic therapy following bioprosthetic aortic valve replacement.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Antithrombotic therapy following bioprosthetic aortic valve replacement.
@ast
Antithrombotic therapy following bioprosthetic aortic valve replacement.
@en
type
label
Antithrombotic therapy following bioprosthetic aortic valve replacement.
@ast
Antithrombotic therapy following bioprosthetic aortic valve replacement.
@en
prefLabel
Antithrombotic therapy following bioprosthetic aortic valve replacement.
@ast
Antithrombotic therapy following bioprosthetic aortic valve replacement.
@en
P2093
P2860
P1476
Antithrombotic therapy following bioprosthetic aortic valve replacement.
@en
P2093
Emma Wilton
Hugh Markus
Justin Nowell
Marjan Jahangiri
P2860
P304
P356
10.1016/J.EJCTS.2006.12.017
P577
2007-01-30T00:00:00Z